Industry-sponsored satellite symposia at the 23rd EURETINA Congress

News
Article

Attendees can take advantage of many satellite symposia, sponsored by industry and feauring experts from around the world

A bridge and bicycles in Amsterdam. Image credit: ©andreykr – stock.adobe.com

During the EURETINA congress, there will be 1-hour symposia sessions on Thursday, Friday and Saturday. Image credit: ©andreykr – stock.adobe.com

The 23rd annual EURETINA Congress will be held from October 5 to October 7 in Amsterdam, the Netherlands. The venue is RAI Amsterdam.

In addition to the numerous educational opportunities offered by the Congress program, attendees also can take advantage of many satellite symposia sponsored by industry. Experts from around the world will present during the symposia.

The following are the titles of the 1-hour symposia sessions. All times listed are expressed in Central European Summer Time (CEST).

Thursday October 5

  • 13:30 – 14:30 CEST: Change in treatment paradigm for DME with faricimab: Evidence from clinical trials and real-world practice (sponsored by Roche)

Friday October 6

  • 09:45 - 10:45 CEST: Eye to Eye - Maximize your surgical approach (sponsored by Alcon)
  • 09:45 - 10:45 CEST: Current management of inherited retinal diseases: the X-linked retinitis pigmentosa perspective (sponsored by Janssen)
  • 09:45 - 10:45 CEST: Have we maximised patient outcomes, or can we go further? (sponsored by Bayer)
  • 13:45 - 14:45 CEST: Modern imaging and algorithms for interrogating chorioretinal disease (sponsored by Nidek)
  • 13:45 - 14:45 CEST: Exploring diabetic macular edema: clinical considerations and perspectives on its management (sponsored by Novartis)
  • 13:45 - 14:45 CEST: Informed decision-making every step of the way - PART 1 : Diagnostic imaging in disease management (sponsored by Zeiss)
  • 13:45 - 14:45 CEST: Change in treatment paradigm for nAMD with faricimab: Evidence from clinical trials and real-world practice (sponsored by Roche)
  • 13:45 - 14:45 CEST: Advances in ultra-widefield multimodal retinal imaging - learn from our experts (sponsored by Optos)
  • 17.45 - 18.45 CEST: The future of continuous drug delivery for retinal diseases (sponsored by Roche)

Saturday October 7

  • 10:15 - 11:15 CEST: Is sustained disease control the new benchmark for patient care? (sponsored by Bayer)
  • 10:15 - 11:15 CEST: Laser for retina and vitreous: All you need to know in 2023 (sponsored by Lumibird)
  • 10:15 - 11:15 CEST: Informed decision-making every step of the way - Part 2: Visualization in vitreoretinal surgery (sponsored by Zeiss)
  • 10:15 - 11:15 CEST: Discovering ChANGe with Ang-2 (sponsored by Roche)
  • 10:15 - 11:15 CEST: IME: Dry AMD & GA IME Platform: practical considerations for GA treatment (sponsored by the Euretina Education Platform)
  • 13:00 - 14:00 CEST: Geographic atrophy: navigating to the future (sponsored by Apellis)
  • 13:00 - 14:00 CEST: What is Bayer’s vision for the future of ophthalmology? (sponsored by Bayer)
  • 13:00 - 14:00 CEST: New dimensions in visualization: changing the way you look (sponsored by Bausch & Lomb)
  • 13:00 - 14:00 CEST: High-resolution OCT in retinal disorders including atrophic AMD (sponsored by Heidelberg Engineering)
  • 13:00 - 14:00 CEST: LIGHTSITE III pivotal trial 24-month analysis: multiwavelength Valeda® Light Delivery System Treatment in early/intermediate dry age-related macular degeneration patients(sponsored by LumiThera)
  • 18:00 - 19:00 CEST: Retinale® - EURETINA Kompakt (sponsored by Roche)

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
Related Content
© 2025 MJH Life Sciences

All rights reserved.